GlucoTrack Past Earnings Performance

Past criteria checks 0/6

GlucoTrack has been growing earnings at an average annual rate of 41.6%, while the Medical Equipment industry saw earnings growing at 9.8% annually. Revenues have been declining at an average rate of 76.4% per year.

Key information

41.6%

Earnings growth rate

78.1%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate-76.4%
Return on equity-2,323.9%
Net Marginn/a
Last Earnings Update31 Mar 2024

Recent past performance updates

No updates

Recent updates

GlucoTrack to start R&D program for glucose monitoring system

Oct 10

Revenue & Expenses Breakdown

How GlucoTrack makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:GCTK Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 240-1036
31 Dec 230-825
30 Sep 230-724
30 Jun 230-622
31 Mar 230-522
31 Dec 220-422
30 Sep 220-532
30 Jun 220-522
31 Mar 220-422
31 Dec 210-422
30 Sep 210-321
30 Jun 210-321
31 Mar 210-321
31 Dec 200-321
30 Sep 200-212
30 Jun 200-312
31 Mar 200-322
31 Dec 190-422
30 Sep 190-3522
30 Jun 190-3723
31 Mar 190-3833
31 Dec 180-4043
30 Sep 181-1163
30 Jun 181-1173
31 Mar 181-1173
31 Dec 171-1283
30 Sep 170-1072
30 Jun 170-952
31 Mar 171-843
31 Dec 161-633
30 Sep 160-633
30 Jun 160-633
31 Mar 160-632
31 Dec 150-622
30 Sep 150-522
30 Jun 150-522
31 Mar 150122
31 Dec 140222
30 Sep 140-522
30 Jun 140-512
31 Mar 140-1012
31 Dec 130-1012
30 Sep 130-412

Quality Earnings: GCTK is currently unprofitable.

Growing Profit Margin: GCTK is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: GCTK is unprofitable, but has reduced losses over the past 5 years at a rate of 41.6% per year.

Accelerating Growth: Unable to compare GCTK's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: GCTK is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.6%).


Return on Equity

High ROE: GCTK has a negative Return on Equity (-2323.94%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.